Chetan Bettegowda, Ph.D.
Affiliations: | 2005 | Johns Hopkins University, Baltimore, MD |
Area:
OncologyGoogle:
"Chetan Bettegowda"Parents
Sign in to add mentor| Kenneth W. Kinzler | grad student | 2005 | Johns Hopkins | |
| (Bactriolytic therapy for cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nichakawade TD, Ge J, Mog BJ, et al. (2024) TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature |
| Douville C, Lahouel K, Kuo A, et al. (2024) Machine learning to detect the SINEs of cancer. Science Translational Medicine. 16: eadi3883 |
| Cook AL, Sur S, Dobbyn L, et al. (2023) Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape. Biorxiv : the Preprint Server For Biology |
| Wright KM, DiNapoli SR, Miller MS, et al. (2023) Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. Nature Communications. 14: 5063 |
| Mattox AK, Douville C, Wang Y, et al. (2023) The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer. Cancer Discovery |
| Douville C, Curtis S, Summers M, et al. (2023) Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid. Cell Reports. Medicine. 4: 101148 |
| Rincon-Torroella J, Molin MD, Mog B, et al. (2023) ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1. Biorxiv : the Preprint Server For Biology |
| Wang Y, Douville C, Cohen JD, et al. (2023) Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220704120 |
| Lu S, Mattox AK, Aitana Azurmendi P, et al. (2023) The rapid and highly parallel identification of antibodies with defined biological activities by SLISY. Nature Communications. 14: 17 |
| Cook AL, Wyhs N, Sur S, et al. (2022) An isogenic cell line panel for sequence-based screening of targeted anticancer drugs. Iscience. 25: 104437 |